Email Updates

Search form

You are here

Webinar & Meeting Reports

  • April 26, 2017

    In this webinar, we were joined by Dr. James Kiarie, coordinator of the Human Reproduction Team at the World Health Organization. Dr. Kiarie presented new guidance from WHO on hormonal contraceptive eligibility for women at high risk of HIV. He also fielded questions from webinar participants.

  • April 4, 2017

    Hundreds of people tuned in to hear researchers discuss the available data on “time to protection” required for effective oral PrEP with TDF/FTC—i.e., how many doses must be taken to build up protective levels of the drug in the blood? The answer is—it varies. Not surprisingly then, so do the guidelines for PrEP use.

  • March 20, 2017

    IPM, AVAC, Dalberg Design Impact Group and the USAID Center for Accelerating Innovation and Impact held a side event during the 61st session of the United Nations Commission on the Status of Women. The conversation brought together stakeholders working to advance women's empowerment by building bridges between global health and economic empowerment initiatives.

  • March 10, 2017

    In this call, panelists discussed what the WHO grading system for family planning methods is, what impact a change in classification for DMPA and NET-EN has for women, programs and research, and what needs to happen next.

  • February 13, 2017 to February 16, 2017

    The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases.

  • February 9, 2017

    There has been lots of discussion about the different PrEP guidelines with respect to how long it takes women to get protection with oral PrEP. This webinar tried to help us all understand the data that do exist and how the different guidelines emerged. The call featured pharmacologists who’ve generated much of the data to briefly present their data and interpretations. This was followed by a Q&A period.

  • January 19, 2017 to January 22, 2017
    This conference is an opportunity to present research and community-defined evidence practices that demonstrate promising outcomes in achieving the goals of the National HIV/AIDS Strategy.
  • January 18, 2017

    The search for new preventive and treatment technologies such as pre-exposure prophylaxis (PrEP), HIV vaccines, microbicides and male hormonal contraceptives continue to make progress, but condoms will remain a key component of combination prevention strategies individuals can choose at different times in their lives to reduce their risks of sexual exposure to HIV and prevent unintended pregnancy.

  • December 15, 2016

    Join Treatment Action Group and HIV PJA for an online discussion about possibilities for monitoring progress toward the National HIV/AIDS Strategy and what community advocates and other key stakeholders need to know about how we measure success in our national HIV prevention efforts.

  • December 3, 2016 to December 4, 2016

    The National HIV PrEP Summit (NHPS) is a new NMAC conference slated for December 3-4, 2016 in San Francisco. The meeting brings together HIV leaders to discuss and learn about PrEP and other biomedical HIV prevention interventions.

Pages